According to a new study by researchers at Wake Forest Baptist Medical Center released Thursday, less than 45% of children were vaccinated against the flu during a five-year study period.
A new drug for treating attention deficit hyperactivity disorder made by Pfizer is now available, the drug maker said.
Medagate, a wholly owned subsidiary of InComm Holdings, announced the launch of the MasterCard Dual Value Health Card, the first dual network healthcare spending card.
The worst of the flu season may be over, at least for those in the South.
Ferndale Healthcare unveiled a redesigned corporate web site Ferndalehealthcare.com to make it easier for a variety of target audiences to navigate the site.
A panel of Food and Drug Administration experts has recommended approval for an experimental Type 2 diabetes drug made by Johnson & Johnson, the drug maker said.
Growth in the consumer products market is likely to slow down over the next five years, while pharmacy retailers will see a profit windfall due to the generic drug cycle, according to a new report.
Demand among consumers for online services from drug companies to help manage chronic conditions is strong, according to a new study from healthcare market research firm Manhattan Research.
The Food and Drug Administration has approved a new intrauterine device for preventing pregnancy made by Bayer HealthCare Pharmaceuticals, the drug maker said.
The Food and Drug Administration is ordering the makers of several sleep drugs to lower the dosage due to the risk that they can impair patients the morning after, the agency said Thursday.